Ken Griffin Athersys, Inc Transaction History

Citadel Advisors LLC

  • $483 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.18 - $0.86 $144,734 - $691,511
804,083 Added 299.01%
1,072,995 $279,000
Q1 2022

May 16, 2022
SELL
$0.6 - $1.06 $49,942 - $88,232
-83,238 Reduced 23.64%
268,912 $163,000
Q4 2021

Feb 14, 2022
SELL
$0.85 - $1.4 $16,854 - $27,760
-19,829 Reduced 5.33%
352,150 $316,000
Q3 2021

Nov 15, 2021
BUY
$1.33 - $1.77 $182,679 - $243,114
137,353 Added 58.54%
371,979 $495,000
Q2 2021

Aug 16, 2021
SELL
$1.41 - $1.94 $4,767 - $6,559
-3,381 Reduced 1.42%
234,626 $337,000
Q1 2021

May 17, 2021
BUY
$1.61 - $2.77 $270,143 - $464,781
167,791 Added 238.96%
238,007 $428,000
Q4 2020

Feb 16, 2021
SELL
$1.55 - $2.24 $103,564 - $149,667
-66,816 Reduced 48.76%
70,216 $123,000
Q3 2020

Nov 16, 2020
BUY
$1.91 - $3.08 $54,918 - $88,559
28,753 Added 26.55%
137,032 $267,000
Q1 2020

May 15, 2020
BUY
$1.17 - $3.0 $1,561 - $4,005
1,335 Added 1.25%
108,279 $325,000
Q4 2019

Feb 14, 2020
BUY
$1.16 - $1.42 $92,528 - $113,267
79,766 Added 293.49%
106,944 $132,000
Q3 2019

Nov 14, 2019
SELL
$1.21 - $1.65 $55,630 - $75,860
-45,976 Reduced 62.85%
27,178 $36,000
Q2 2019

Aug 14, 2019
BUY
$1.39 - $2.03 $37,741 - $55,118
27,152 Added 59.02%
73,154 $123,000
Q1 2019

May 15, 2019
SELL
$1.39 - $1.71 $119,934 - $147,545
-86,284 Reduced 65.23%
46,002 $0
Q4 2018

Feb 14, 2019
SELL
$1.41 - $2.16 $38,284 - $58,648
-27,152 Reduced 17.03%
132,286 $190,000
Q3 2018

Nov 13, 2018
BUY
$1.86 - $2.18 $211,506 - $247,894
113,713 Added 248.69%
159,438 $0
Q2 2018

Aug 10, 2018
BUY
$1.76 - $2.79 $54,239 - $85,982
30,818 Added 206.74%
45,725 $0
Q1 2018

May 11, 2018
SELL
$1.34 - $2.03 $11,513 - $17,441
-8,592 Reduced 36.56%
14,907 $27,000
Q4 2017

Feb 09, 2018
SELL
$1.65 - $2.45 $3,931 - $5,838
-2,383 Reduced 9.21%
23,499 $43,000
Q3 2017

Nov 09, 2017
BUY
$1.5 - $2.55 $38,823 - $65,999
25,882
25,882 $54,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email